HomeNewsWorldSerbia to start COVID-19 vaccinations on December 24

Serbia to start COVID-19 vaccinations on December 24

Serbia, an EU candidate country home to seven million people, has lost almost 2,800 to the novel coronavirus while more than 300,000 have been infected.

December 23, 2020 / 18:39 IST
Story continues below Advertisement
Representative image
Representative image

Serbia will begin vaccinating people against COVID-19 on Thursday, President Aleksandar Vucic said Wednesday, making the Balkan state one of the first in Europe to launch a campaign with the Pfizer-BioNTech shot.

Officials said Serbia has received nearly 5,000 doses of the vaccine, which is already in use in the United States and Britain.

Story continues below Advertisement

Meanwhile European Union countries plan to roll out the vaccine on December 27.

"Vaccination starts tomorrow in Serbia," Vucic told the press, adding that the first jabs would go to the elderly in retirement homes.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show